Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 7 of 7 publications.

Bai S, Tornello SL, Mogle JA, Feinberg ME. Daily implementation of health-protective behaviors and family life during the early months of the COVID-19 pandemic. Fam Process. 2024 Mar;63(1):428-42. doi: 10.1111/famp.12870.

Le Y, Mogle JA, Feinberg ME. Trajectories of parent and child well-being across the pandemic year: role of financial strain, social distancing, and COVID-19 prevalence. Fam Process. 2023 Sep;62(3):1134-46. doi: 10.1111/famp.12823

Feinberg ME, Gedaly L, Mogle J, Hostetler ML, Cifelli JA, Tornello SL, Lee JK, Jones DE. Building long-term family resilience through universal prevention: 10-year parent and child outcomes during the COVID-19 pandemic. Fam Process. 2022 Mar;61(1):76-90. doi: 10.1111/famp.12730

Jenkins AIC, Fredman SJ, Le Y, Mogle JA, McHale SM. Religious coping and gender moderate trajectories of marital love among black couples. Fam Process. 2022 Mar;61(1):312-25. doi: 10.1111/famp.12645

Davis AE, Brogan AJ, Goodwin B, Nocea G, Lozano V. Short-term cost and efficiency analysis of raltegravir versus atazanavir/ritonavir or darunavir/ritonavir for treatment-naive adults with HIV-1 infection in Spain. HIV Clin Trials. 2017 Nov;18(5-6):214-22. doi: 10.1080/15284336.2017.1402144

Hansen MK, Gammelager H, Jacobsen CJ, Hjortdal VE, Layton JB, Rasmussen BS, Andreasen JJ, Johnsen SP, Christiansen CF. Acute kidney injury and long-term risk of cardiovascular events after cardiac surgery: a population-based cohort study. J Cardiothorac Vasc Anesth. 2015 Jun;29(3):617-25. doi: 10.1053/j.jvca.2014.08.020

Brogan AJ, Mrus J, Hill A, Sawyer AW, Smets E. Comparative cost-efficacy analysis of darunavir/ritonavir and other ritonavir-boosted protease inhibitors for first-line treatment of HIV-1 infection in the United States. HIV Clin Trials. 2010 May;11(3):133-44.